Brands: Ozempic · Rybelsus · Semaglutide
Average across 6 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume - Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Novo Nordisk | unknown | 8 | SUPPLYING |
Shortages, recalls, and registration changes attached to this drug concept.
Semaglutide Tablet — reported in shortage by Novo Nordisk, Inc.. Therapeutic category: Endocrinology/Metabolism.
Semaglutide Tablet — reported in shortage by Novo Nordisk, Inc.. Therapeutic category: Endocrinology/Metabolism.
CGMP Deviations: Intermittent exposure to temperature excursion during storage. — Recalling firm: Cardinal Health Inc. — FL, GA, SC
